Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1957 1
1958 1
1961 2
1964 2
1965 1
1966 1
1967 1
1968 2
1969 4
1970 8
1971 8
1972 12
1973 16
1974 22
1975 14
1976 17
1977 15
1978 31
1979 34
1980 38
1981 31
1982 22
1983 27
1984 32
1985 36
1986 28
1987 41
1988 35
1989 43
1990 42
1991 59
1992 65
1993 61
1994 82
1995 87
1996 92
1997 101
1998 109
1999 114
2000 134
2001 175
2002 178
2003 201
2004 273
2005 280
2006 340
2007 374
2008 419
2009 461
2010 524
2011 621
2012 598
2013 677
2014 694
2015 839
2016 828
2017 855
2018 892
2019 1002
2020 1234
2021 1406
2022 1559
2023 1377
2024 587

Text availability

Article attribute

Article type

Publication date

Search Results

15,962 results

Results by year

Filters applied: . Clear all
Page 1
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.
Ramalingam SS, Vansteenkiste J, Planchard D, Cho BC, Gray JE, Ohe Y, Zhou C, Reungwetwattana T, Cheng Y, Chewaskulyong B, Shah R, Cobo M, Lee KH, Cheema P, Tiseo M, John T, Lin MC, Imamura F, Kurata T, Todd A, Hodge R, Saggese M, Rukazenkov Y, Soria JC; FLAURA Investigators. Ramalingam SS, et al. Among authors: lin mc. N Engl J Med. 2020 Jan 2;382(1):41-50. doi: 10.1056/NEJMoa1913662. Epub 2019 Nov 21. N Engl J Med. 2020. PMID: 31751012 Free article. Clinical Trial.
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation.
Sacher A, LoRusso P, Patel MR, Miller WH Jr, Garralda E, Forster MD, Santoro A, Falcon A, Kim TW, Paz-Ares L, Bowyer S, de Miguel M, Han SW, Krebs MG, Lee JS, Cheng ML, Arbour K, Massarelli E, Choi Y, Shi Z, Mandlekar S, Lin MT, Royer-Joo S, Chang J, Dharia NV, Schutzman JL, Desai J; GO42144 Investigator and Study Group. Sacher A, et al. Among authors: lin mt. N Engl J Med. 2023 Aug 24;389(8):710-721. doi: 10.1056/NEJMoa2303810. N Engl J Med. 2023. PMID: 37611121 Free article. Clinical Trial.
Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial.
Liu X, Dai Q, Ye R, Zi W, Liu Y, Wang H, Zhu W, Ma M, Yin Q, Li M, Fan X, Sun W, Han Y, Lv Q, Liu R, Yang D, Shi Z, Zheng D, Deng X, Wan Y, Wang Z, Geng Y, Chen X, Zhou Z, Liao G, Jin P, Liu Y, Liu X, Zhang M, Zhou F, Shi H, Zhang Y, Guo F, Yin C, Niu G, Zhang M, Cai X, Zhu Q, Chen Z, Liang Y, Li B, Lin M, Wang W, Xu H, Fu X, Liu W, Tian X, Gong Z, Shi H, Wang C, Lv P, Tao Z, Zhu L, Yang S, Hu W, Jiang P, Liebeskind DS, Pereira VM, Leung T, Yan B, Davis S, Xu G, Nogueira RG; BEST Trial Investigators. Liu X, et al. Among authors: lin m. Lancet Neurol. 2020 Feb;19(2):115-122. doi: 10.1016/S1474-4422(19)30395-3. Epub 2019 Dec 9. Lancet Neurol. 2020. PMID: 31831388 Clinical Trial.
Accelerating scientific discoveries through data-driven innovations.
Alexander FJ, Lin M, Qian X, Yoon BJ. Alexander FJ, et al. Among authors: lin m. Patterns (N Y). 2023 Nov 10;4(11):100876. doi: 10.1016/j.patter.2023.100876. eCollection 2023 Nov 10. Patterns (N Y). 2023. PMID: 38035189 Free PMC article. No abstract available.
CCR5 and inflammatory storm.
Lin Y, Liu S, Sun Y, Chen C, Yang S, Pei G, Lin M, Yu J, Liu X, Wang H, Long J, Yan Q, Liang J, Yao J, Yi F, Meng L, Tan Y, Chen N, Yang Y, Ai Q. Lin Y, et al. Among authors: lin m. Ageing Res Rev. 2024 Apr;96:102286. doi: 10.1016/j.arr.2024.102286. Epub 2024 Mar 30. Ageing Res Rev. 2024. PMID: 38561044 Review.
15,962 results
You have reached the last available page of results. Please see the User Guide for more information.